Roche’s breast, lung cancer offerings fail to impress at ASCO
June 4, 2018Research and Development, Sales and Marketing ASCO, Cancer, Roche, breast cancer, lung cancer, pharma, taselisib, tecentriq
Roche made an underwhelming impact at the American Society of Clinical Oncology (ASCO) annual event in Chicago, after revealing data …
Milan’s decision to appeal the EMA HQ relocation explained
June 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Milan, biotech, drugs, pharma, pharmaceutical
The decision to award the EMA headquarters to Amsterdam was a contentious one, not least because the vote had to …
Amgen/Novartis migraine med gets CHMP nod
June 4, 2018Sales and Marketing Aimovig, Amgen, Novartis, biotech, drugs, pharma, pharmaceutical
Amgen and Novartis have announced that their newly FDA-approved treatment for migraines has received a recommendation from the CHMP, generally …
Keytruda offers significant hope in subset of prostate cancer
June 4, 2018Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, prostate cancer
Up until present, no studies had shown that immunotherapies could offer potential treatment for men with prostate cancer; however, at …
Celgene bring in new CFO to steady the ship
June 4, 2018Medical Communications, Sales and Marketing Celgene, Johnson & Johnson, biotech, drugs, pharma, pharmaceutical
The fact that Celgene is currently sailing through choppy waters is no secret to anyone within the industry, it’s facing …
Top Ten most popular articles on Pharmafile.com this week
June 1, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Allergan, AstraZeneca, Cancer, Gilead, HIV, J&J, JJ, google, machine learning, melanoma, pharma, top ten
The first day of June – time for another top ten run-down. It’s been a week somewhat characterised by trial …
Kitov’s combo gets FDA approval in osteoarthritis and hypertension
June 1, 2018Medical Communications, Sales and Marketing Consensi, FDA, Kitov, US, hypertension, osteoarthritis, pharma
Israeli biopharmaceutical firm is celebrating the approval in the US of Consensi, a combo of the calcium channel blocker amlodipine …
Bayer eyes R&D cuts, as Monsanto deal raises question of focus
June 1, 2018Medical Communications Bayer, biotech, drugs, monsanto, pharma, pharmaceutical
When rumours first started rumbling about a mega-merger between Bayer and Monsanto, one of the major question marks was on …
Roche resigns itself to failure on SMA drug
June 1, 2018Medical Communications Roche, biotech, drugs, pharma, pharmaceutical, spinal muscular atrophy
Roche has announced that it will no longer seek to develop its treatment for spinal muscular atrophy (SMA), olesoxime, after …
Novartis’ US Oncology head makes leap to become biotech CEO
June 1, 2018Medical Communications Novartis, axcella, biotech, drugs, pharma, pharmaceutical
The departure of high-level, big pharma executives to tiny biotechs is steadily becoming a constant stream; the latest is Bill …
Head of Sandoz UK becomes BGMA chair
May 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sandoz, appointment, bgma, pharma
Tim de Gavre has been announced as the new chair for the British Generic Manufacturers Association (BGMA), a position he …
Staff shortfall leads to massive deficit for NHS
May 31, 2018Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
The headline figure is that the NHS budget deficit for the year 2017/2018 came in at £960 million, close to …
Pfizer’s Xeljanz becomes first JAK inhibitor approved in US for active ulcerative colitis
May 31, 2018Sales and Marketing FDA, Pfizer, US, Xeljanz, pharma, ulcerative colitis
Pfizer has revealed that its Janus kinase (JAK) inhibitor Xeljanz (tofacitinib) has received FDA approval for the treatment of adult …
Allergan aims to appease investors with non-core units sell off
May 31, 2018Medical Communications Allergan, biotech, drugs, pharma, pharmaceutical
Allergan’s share price has been on a steady downward trajectory for the last year and investors are becoming increasingly frustrated …
The June 2018 issue of Pharmafocus is now live!
May 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ebola, GDPR, Trump, UK, brexit, data managment, market access, pharma
The new June edition of Pharmafocus is now available to read online.
FDA approval for TherapeuticsMD, one year after initial rejection
May 30, 2018Sales and Marketing FDA, TherapeuticsMD, biotech, drugs, pharma, pharmaceutical
TherapeuticsMD has succeeded in changing the FDA’s mind on its Imvexxy product, after an initial rejection in May of last …
Insider Interview: Gilead’s fight against HIV comes into bloom
May 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, HIV, Insider Interview, pharma
Mike Elliott, Vice President of Medical Affairs at Gilead (pictured, right), chats about the company’s sponsorship of a ‘A life …
Google AI outperforms 58 dermatologists in detecting melanoma
May 30, 2018Research and Development AI< Google, Cancer, melanoma, pharma, skin cancer
An deep learning artificial intelligence system has demonstrated its ability to outperform over 50 human dermatologists in the detection of …
Envision Pharma Group supports Otsuka’s medical affairs activities
May 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Envision Pharma Group
Envision Pharma Group announces the successful implementation of iEnvision to connect and support Otsuka’s medical affairs activities. Otsuka Pharmaceutical Development …
AZ’s hopes for Fasenra in COPD suffer terminal blow
May 30, 2018Research and Development AstraZeneca, Fasenra, GSK, Nucala, biotech, drugs, pharma, pharmaceutical
It looked unlikely that Fasenra would achieve success in the chronic obstructive pulmonary disease (COPD) area, after it suffered in …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
